Catalyst OrthoScience

Catalyst OrthoScience is an early-stage medical device company that has introduced the Catalyst CSR total shoulder to the market. The company's innovative approach prioritizes a more natural solution and rapid patient recovery by minimizing the stretching of muscles and ligaments during implantation, and focusing on providing a more natural fit for the patient. Founded in 2014, their recent $1.50M Venture Round investment on April 18, 2024, reflects investor confidence in the potential of their innovative shoulder replacement solution. The firm's commitment to revolutionizing shoulder implant placement in the healthcare industry makes it a prominent player in the market. With a substantial focus on patient-centric innovation, Catalyst OrthoScience is poised to make a significant impact in the medical device sector.